BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help

Documents 1-17 out of 17 found
  Current Search:  abraxane: 20, paclitaxel: 5142  

100%
HTML
Paclitaxel - [Medication] - Quest Diagnostics Patient Health Library
Paclitaxel Examples Brand Name Chemical Name Taxol, Abraxane paclitaxel How It Works Paclitaxel interferes with the cancer cell's ability to reproduce.
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About Paclitaxel - [Medication] - Quest Diagnostics Patient Health Library Paclitaxel ...
Matching: abraxane paclitaxel Find similar documents More document info
100%
HTML
Results -- View
- - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
Matching: Find similar documents More document info
100%
HTML
Results -- View
- - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
Matching: Find similar documents More document info
100%
HTML
BioPortfolio Limited Datamonitor Oncology Reports 2005
Scope > Analysis of current treatment practices for early-stage breast cancer based on primary research from 180 physicians in the seven major markets > Extent of use of antihormonal agents, such as anti-estrogens and aromatase inhibitors, in local and locally-advanced breast cancer > Physician awareness and ratings of late-stage pipeline drugs for breast cancer,...
Matching: abraxane paclitaxel Find similar documents More document info
100%
HTML
BioPortfolio Limited Datamonitor Oncology Reports 2004
Much earlier relief will be in the form of American BioScience's Abraxane, a reformulated paclitaxel currently in preregistration.
With significant advantages over Bristol-Myers Squibb's Taxol, Abraxane is set to become a key cytotoxic.
Gemzar is already a blockbuster drug for other tumors, and is predicted to see significant uptake and crossover from ...
Matching: abraxane paclitaxel Find similar documents More document info
100%
HTML
BioPortfolio Limited
Breast Cancer - Changing Treatment Paradigms for Local and Locally Advanced Breast Cancer TABLE OF CONTENTS About Datamonitor Healthcare 2 About the Oncology pharmaceutical analysis team 2 CHAPTER 1 EXECUTIVE SUMMARY 3 CHAPTER 2 E EMIOLOGY 10 US 12 Japan 13 France 14 Germany 15 Italy 16 Spain 17 UK 18 CHAPTER 3 TUMOR CHARACTERISTICS 19 Introduction 19 Hormone-receptor status 19 HER2...
Matching: abraxane paclitaxel Find similar documents More document info
100%
HTML
Emerging oncology treatments: A focus on targeted therapeutics, supergeneric reformulations and supportive care
Supergeneric versions of Taxol, such as Cell Therapeutics' Xyotax (polyglutamate paclitaxel) and Abraxis Oncology's Abraxane (nanoparticle albumin-bound paclitaxel) have been developed and offer significant advantages over Taxol in terms of adverse effects and drug delivery.
Supergeneric versions of Taxol, such as Cell Therapeutics' Xyotax (polyglutamate ...
Matching: abraxane paclitaxel Find similar documents More document info
100%
HTML
BioPortfolio Limited
With aromatase inhibitors and Eli Lilly’s Evista (raloxifene) both vying to replace tamoxifen for two different indications, tough competition characterizes the market for existing approved agents with high barriers to entry for new agents 12 Summary analysis 14 Key metrics 15 CHAPTER 2 BREAST CANCER PATIENT POTENTIAL 29 Definition of breast cancer 29 Types of breast cancer 29...
Matching: abraxane paclitaxel Find similar documents More document info
100%
HTML
BioPortfolio Limited
Cancer Overview - Numerous Diverse Drugs Approaching Fruition TABLE OF CONTENTS About the Oncology pharmaceutical analysis team 2 Richard Faint – Director of Oncology 2 CHAPTER 1 KEY FINDINGS 3 Datamonitor insight into the oncology market 3 Key metrics 9 Datamonitor pipeline assessment summary 17 CHAPTER 2 CANCER PATIENT POTENTIAL 38 Introduction 38 Definition of cancer 38...
Matching: abraxane paclitaxel Find similar documents More document info
100%
HTML
Database P
P - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products To purchase documents on-line click on- -link attached to selected document!- The fee is $15 per document Documents are delivered by e-mail...
Matching: abraxane paclitaxel Find similar documents More document info
100%
HTML
Database A
A - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products.
See SAIK-MS (2806) Abraxane ™ (ABI-007, Paclitaxel Albumin Stabilized Nanopartice Formulated) (2824) Abreva ™* ...
Matching: abraxane paclitaxel Find similar documents More document info
66%
HTML
Results -- View
- - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
Matching: Find similar documents More document info
66%
HTML
BioPortfolio Limited BioSeeker 2005
This Analytical Tool includes three parts: Breast Cancer: The Latest R&D Trends Basic Platform Report: Breast Cancer Business Development and R&D Database: Breast Cancer Example of candidates included: The complete number of candidate drugs in clinical research for breast cancer, are more than 150, and some of them below are listed below: Abraxane, Alimta, Arimidex,...
Matching: abraxane Find similar documents More document info
66%
HTML
BioPortfolio Limited Drug and Market Development 2005
[ Home ] - [ Up ] - [ Catalog ] - [ Info ] - [ Search ] - [ View Basket ] - [ Checkout ] - [ Send email ] - BioPortfolio accept VISA, MASTERCARD and AMEX Bioportfolio - - Drug and Market Development 2005 The Bioprocess Report - Trends in Biopharmaceutical Manufacturing Technology Report Overview The Bioprocess Report represents a breakthrough for the biopharmaceutical industry.
&...
Matching: abraxane Find similar documents More document info
66%
HTML
BioPortfolio Limited
70 Protiveris 71 Sequenom 71 Zyomyx 72 Future developments 73 Chapter 3 Nanotechnology 77 Summary 77 Introduction 78 Nanotechnologies 79 Applications 81 Drug discovery and drug delivery 81 Biosensing 82 Other applications 82 v Public opinion 82 Funding 83 Market 84 Nano-enabled drug discovery tools 84 Atomic force microscopy 85 Nano-mass spectroscopy 86 Dip-pen nanolithography 87...
Matching: abraxane Find similar documents More document info
66%
HTML
Innovatives & supportive care way forward for Cancer drugs
- - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
Matching: abraxane Find similar documents More document info
66%
HTML
BioPortfolio Limited
The Impact of Nanotechnology in Drug Discovery Chapter Summary 1 Executive Summary 2 Introduction Overview Objectives Scope of the Report/Research Methodology and Information Sources Plan of Report 3 Drivers, Restraints, Challenges, Regulatory Issues and Government Funding Policies Introduction Drivers for the Growth of Nano-enabled Drug Discovery Social and economic drivers...
Matching: abraxane Find similar documents More document info

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.